Riverine Ventures

Riverine Ventures is a venture capital firm investing in next-generation life science and healthcare companies. It targets early-stage private companies developing breakthrough biomedical technologies. Its strategy centers on precision medicine, focusing on therapeutics, devices, diagnostics, and data-driven insights. This approach aims to improve patient outcomes through robust scientific and clinical value.

Founded in 2022 by Garrett Vygantas, MD, MBA, and Scott Robert Lancaster, MD, MBA, the firm leverages its principals' expertise. Dr. Vygantas, a physician and entrepreneur, brings biopharma and healthcare investing experience. Dr. Lancaster, a board-certified diagnostic radiologist, offers clinical and business acumen. Their insight was to partner with leaders solving complex life science challenges.

The firm serves early-stage companies and entrepreneurs in biomedical and health technology, providing capital and partnership. Riverine Ventures fosters innovation by collaborating with portfolio companies, enhancing capital efficiency and accelerating development. Its vision is to drive transformative change by supporting solutions for unmet medical needs, advancing global healthcare.